Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy [Phase 1, Phase 2]
A phase 1/2 trial evaluating targeted radiotherapy in hematopoietic stem cell transplantation for poor risk hematologic malignancies has com…
-
CLINICAL_TRIALS trial_result · 2019-03-27Clinical Trial Update: Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating double cord blood transplant for malignant and non-malignant disorders; study terminated with results po…
-
CLINICAL_TRIALS trial_result · 2019-03-25Clinical Trial Update: Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib [Phase 1]
Phase 1 trial evaluating safety, tolerability, PK of esomeprazole with rifampin and a QT study for alisertib in solid tumors and lymphoma.
-
CLINICAL_TRIALS trial_result · 2019-03-15Clinical Trial Update: Study Evaluating The Safety And Tolerability Of Combination Therapy Inotuzumab Ozogamicin (CMC-544) And Rituximab [Phase 1]
Phase 1 study evaluating safety and tolerability of the combination of Inotuzumab Ozogamicin (CMC-544) and rituximab in lymphoma, B-cell ind…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating rituximab and cyclophosphamide followed by vaccine therapy in relapsed Hodgkin lymphoma has completed with result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Relaxation and Exercise In Lymphoma Patients [NA]
A completed clinical trial update examining relaxation and exercise in lymphoma patients and its impact on quality of life.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 open-label, multiple ascending dose study of DS-3078a, a TORC1/2 kinase inhibitor, in adults with advanced solid tumors or lymphoma;…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Open-label Study of DS-8273a to Assess Its Safety and Tolerability, and Assess Its Pharmacokinetic and Pharmacodynamic Properties in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1]
This update reports the completion of an open-label Phase 1 trial of DS-8273a in subjects with advanced solid tumors or lymphomas, assessing…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies [Phase 1, Phase 2]
This update reports phase 1/2 results for busulfan-fludarabine conditioning followed by T-cell depleted allogeneic stem cell transplantation…
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of SCT-I10A in Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
This is a Phase 1 clinical trial update evaluating SCT-I10A in patients with advanced solid tumors or lymphoma, focusing on safety, tolerabi…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies.
The study investigates polymorphisms in the IgH locus regulatory region as a prognostic factor in immune pathologies, with the trial status …
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma [NA]
This update reports the completion of a clinical trial investigating CD19 CAR T-cell immunotherapy for relapsed or refractory CD19+ leukemia…
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies [Phase 1, Phase 2]
A multi-phase early-stage clinical trial evaluating CAR-T cell therapy for relapsed or refractory hematologic malignancies including leukemi…
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation with sirolimus and treated immune cells, for blood and lymph cancers, terminated wi…
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection [Phase 4]
Phase 4 trial update on preemptive ethanol lock therapy in pediatric patients with leukemia/lymphoma undergoing treatment; study completed w…
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: Ibrutinib Post Stem Cell Transplantation (SCT) in Double-Hit B-Cell Lymphoma [Phase 2]
Phase 2 trial evaluating ibrutinib after stem cell transplantation in double-hit B-cell lymphoma has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-03Clinical Trial Update: CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy [Phase 1, Phase 2]
Preliminary update on CD19-directed CAR T cell therapy for relapsed/refractory B cell malignancies across Phase 1 and Phase 2 trials.
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: Combination Chemotherapy in Treating Patients With Lymphoma [Phase 3]
A Phase 3 clinical trial evaluating combination chemotherapy in lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies [Phase 2]
Phase 2 trial evaluating liposomal vincristine in pediatric and adolescent patients with relapsed malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma [Phase 2, Phase 3]
Phase II/III randomized study evaluating fludarabine/cyclophosphamide with or without rituximab in untreated mantle cell lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib [Phase 1]
Phase 1 pharmacokinetics and metabolism study of alisertib completed; reports mass balance data in advanced solid tumors and lymphoma.
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach [Phase 2]
Phase 2 clinical trial update on antibiotic therapy and antacids for Malt lymphoma of the stomach (gastric MALT lymphoma) completed.
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma [Phase 1]
Phase 1 trial update for a drug interaction study of tasisulam in patients with advanced cancer or lymphoma; study terminated with results p…
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor [Phase 4]
A Phase 4 clinical trial evaluating G-CSF alone or in combination with GM-CSF for prevention and treatment of infection in children with mal…
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma [Phase 1, Phase 2]
Phase I/II trial evaluating Velcade (bortezomib) plus Zevalin in relapsed or refractory follicular lymphoma has terminated with results post…